Tuesday, September 01, 2015 12:13:39 AM
I guess though this brings up again a criticism that some of us have had for some time on why it made no sense to suddenly expand to the UK. People kept insisting that it was just an easy production for a distributor and then a check at a profit comes back in upon delivery of the shipment, but this was not the case based on the statement that it is costly to enter a new market, plus the UK required reformulation of the product from the US version. Focusing on getting SoCal towards being on stable financial footing first, especially if they used 1 billion extra shares for Avanzar at shareholders' expense would have been a better idea IMO. The company may ultimately be successful, but shareholders are financing the cash burn and being diluted.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM